Keyphrases
North America
100%
Multiple Sclerosis
100%
Research Committee
100%
Symptom Management
100%
Tremor
100%
Symptomatic Medication
28%
Disability
21%
Medication Use
14%
Tremor Severity
14%
Moderate to Severe
7%
Between-group
7%
Poor Prognosis
7%
Anticonvulsant
7%
Aminobutyric Acid
7%
Drug Use
7%
Drug Class
7%
Severity Score
7%
Benzodiazepines
7%
Response to Treatment
7%
Difficult-to-treat
7%
Gabapentin
7%
Clonazepam
7%
Symptomatic Drugs
7%
Unemployment Rate
7%
Medicine and Dentistry
Multiple Sclerosis
100%
Drug Therapy
85%
Symptomatic Treatment
14%
Anticonvulsant
14%
Drug Use
14%
Gabapentin
14%
Gamma-Aminobutyric Acid
14%
Clonazepam
14%
Benzodiazepine Derivative
14%
Neuroscience
Multiple Sclerosis
100%
Tremor
100%
Gamma-Aminobutyric Acid
6%
Gabapentin
6%
Anticonvulsant
6%
Clonazepam
6%